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Background Definition of objective criteria to conclude the severity of MS
is still important.
Aims (1) to evaluate correlation between the mean transmitral gradient
(MTG) and severity of MS in patients with a severe or very severe MS (2) To
analyze the different parameters which determine the mean transmitral gradient.
Methods We conducted a prospective study including fifty patients
admitted for severe or very severe MS, over a period of one year.
We first studied the correlation between mitral valve area and MTG. Then
we separately analyzed two groups of patients: those with a MTG <10mmHg
(group 1) and those with a MTG>10mmHg (group2). We performed for each
group an univariate correlation between MTG and dyspnea, heart rate, cardiac
decompensation, regularity of rhythm, function of right ventricle and systolic
pulmonary artery pressure (SPAP).
Results 64% of our patients had a severe MS and 36% had a very severe
MS. 52% had a MTG <10mmHg and 48% had a mean gradient>10mmHg;
suggesting lack of correlation between the severity of MS and MTG (Pearson
coefficient R: –0.137).
Regarding dyspnea, 80% of patients in group 1 had a dyspnea stage II of
NYHA and 70% of patients in group 2 had a dyspnea stage III (41%) or IV
(29%).
The analytical study of heart rate (HR) and the presence of cardiac decom-
pensation compared with MTG showed a significant correlation. Among the
patients in group 1, 96% had a HR between 60 and 100 bpm and no patient
was in cardiac decompensation. In group 2, 54% (13 patients) had a HR >100
bpm and 7 of them (53%) were in left heart failure. The study of SPAP in the
two groups found a statistically significant correlation between the SPAP and
MTG.
Conclusion Mean transmitral gradient is a good indicator of the tolerance
of mitral stenosis, but it reflects poorly severity because it depends on several
hemodynamic parameters.
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Background Systemic Sclerosis (SSc) represents the main connective
tissue disease associated with PAH.
This PAH is the leading cause of death, which only screening and early
diagnosis can improve prognosis. 
Echocardiographic screening represents so fare the ideal tool for the early
detection of this PAH.
Aim Evaluate the prevalence of PAH in Scleroderma Algerian Population
and its distribution according to clinical forms of the disease.
Methods We conducted a cross-sectional descriptive study from Dec. 2010
to Dec. 2013. 
202 patients (177 women and 25 men) with SSc were enrolled.
We used a screening algorithm based on the maximum velocity of tricuspid
regurgitation (VIT) and dyspnea. This defined patients at high risk (VIT >3 m/s or
VIT between 2.8 and  3 m/s with dyspnea unexplained by another cause). Who
were submitted to right heart catheterization (RHC) to confirm PH.
Results Pulmonary hypertension suspected on echocardiography was
confirmed by RHC in 68.2% of cases.It was a pre-capillary PH.VIT ≥3,48 m/s
strongly suggests PH. 
The prevalence of PAH was 6%. 
The mean delay of it occurrence was 7.08 years after first diagnosis of SSc.
PAH occurred in the first five years in 58.3% of cases and after five years in
41.6% of cases.
It concerns the diffuse cutaneous forms in 33.3% or 0.5% of diffuse forms
of our patient’s population and limited in 58.3% of cases or 0.58% limited
cutaneous forms in our patients population. A frequency of 0,08% was found
in limited form. 
Dyspnea is the primary symptom found, 67% of patients were in class III
and IV at diagnosis.
Conclusion Prevalence of PAH in scleroderma was 6%, our findings are
similar to the results reported in the literature: 
5-12%, through echocardiographic screening and catheterize confirmation.
This strengthens the fact that an echocardiogram should be performed at
the time of SSc diagnostic and this regardless of the clinical form of SSc.
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Introduction Percutaneous mitral commissurotomy (PMC) is the gold stan-
dard technique for the management of severe rhumatismal mitral stenosis
(MS). We investigated the utility of BNP, NT pro-BNP, MR pro-ANP, CD146
and sST2 in evaluating the success of the PMC procedure.
Methods All 5 biomarkers were measured one day before and one day after
the procedure in 43 patients presenting with severe MS (defined as mitral
valve area (VA) by planimetry <0.2cm2) and submitted to PMC in 2 large uni-
versity hospitals in France (CHU Bichat, Paris; CHU Jean Minjoz, Besancon).
Patients were classified as procedural success (VA >1.5cm2 or increase in VA
>0.5cm2) or failure (VA <1.5cm2 or increase in VA <0.5cm2) by echocardiog-
raphy. The absolute decrease in each biomarker between before and after the
procedure was compared for each patient using the paired Student t test. 
Results In total, 43 patients were included (80% women, average
63.7 years), of whom 30 (70%) were judged to have a successful procedure by
echocardiography; 11 (25%) were classed as procedural failure, and 2 (5%)
had a major complication (1 mitral insufficiency requiring surgery, 1 tam-
ponade). Among the 30 patients with procedural success, there was a signifi-
cant decrease in MR pro-ANP (–40±74, p=0.02) and CD146 (–43±105,
p=0.03). There was no significant decrease in patients classed as procedural
failures. There was no significant decrease in BNP, NT pro-BNP or sST2 in
patients with either successful or failed procedure. 
Conclusion There is a significant decrease in MR pro-ANP and CD146
after successful PMC. The difference is more pronounced in younger patients
and in those in sinus rhythm. These two biomarkers could be of use in evalu-
ating the immediate success of PMC. 
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Background Paravalvular aortic regurgitation (PAR) after TAVR has been
associated with increased mortality. The Sapien 3 device (Edwards Life-
sciences) is different than the prior devices released by the same manufacturer
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in that it has a skirt designed to prevent paravalvular leak, improved coaxial
alignment, and more accurate positioning.
Aims To evaluate paravalvular aortic regurgitations after 30-day after
TAVI using the Edwards SAPIEN 3 prosthesis.
Methods Prospective monocentric study including 66 high-risk or non-
operable patients with severe aortic stenosis undergoing TAVI using Edwards
SAPIEN 3 prosthesis via transfemoral access, between September 2014 and
March 2015.
Results Mean age of patient was 84±7,1 years (70% female). The MDCT
estimated an aortic annular diameter 25,07±2mm. Mean logistic EuroSCORE
was 15,8±10,8. In our study, the device success rate was 98.5%. The pros-
thesis has been deployed correctly in all cases and no failure of valve or
embolization had occurred. Post TAVR, mean transaortic gradient decreased
from 46,0±12,33mmHg to 8,2±3,37mmHg (p<0.001). No patient had mod-
erate or severe PAR. At 30 days follow up, transthoracic echocardiography
(TTE) showed that the PAR was absent or trivial in 66% of patients and mild
in the remainder. Possible reasons for this low PAR rate include: 1) the outer
polyethylene terephthalate sealing cuff, which enhances paravalvular sealing;
2) more accurate positioning; and 3) improved sizing with adjunctive MDCT.
Conclusion In our study, TAVI with Edwards SAPIEN 3 demonstrated
lower paravalvular aortic leak rates than earlier generation devices in patients
at high risk for surgery.
The author hereby declares no conflict of interest
0298
Prosthetic valve endocarditis. A 15-years cohort study
Carina Arantes*, Sergia Rocha, Catarina Vieira, Juliana Martins, Glória
Abreu, Catarina Quina-Rodrigues, Antonio Gaspar, Alberto Salgado,
Nuno Salome, Jorge Marques 
Hôpital de Braga, Braga, Portugal
*Corresponding author: arantescarina@gmail.com (Carina Arantes)
Introduction Prosthetic valve endocarditis (PVE) is an uncommon
complication after valve replacement surgery, but potentially fatal. The scar-
city of clinical trials makes harder the diagnostic and therapeutic approach of
this entity. 
Aim To define the clinical characteristics and in-hospital evolution of a
population with PVE. 
Methods Retrospective study based on a sample of 173 patients (P) with
the diagnosis of infective endocarditis (IE), according to the modified Duke
criteria, admitted from 1998 to 2013. We analyzed demographic and clinical
features, complications and in-hospital mortality of P with PVE. 
Results We found 34 P (20%) with PVE, mean age 60.2±17.6 years with
a female predominance (53%). The most common form was the community-
acquired IE, registering 11 P (32%) with health care-associated IE. There was
a preferential engagement of the mitral valve (56%) and 26% had early PVE. 
The cardinal complaints at presentation were constitutional symptoms (97%)
and fever (74%); 50% of P showed signs of acute heart failure (HF). The most
common analytical abnormalities were elevated inflammatory biomarkers (CRP
94% and leukocytosis 41%), anemia (88%) and increased creatinine (60%). 
The microbial agent was isolated in 24 P (71%), being Staphylococcus spp
(26%) and Streptococcus spp (21%) the most common. 
The prosthesis dehiscence (60%), severe regurgitation (29%) and perival-
vular abscess (21%) were the most frequent complications seen at initial echo-
cardiographic evaluation. 
The most common adverse events were acute kidney injury (74%), per-
sistence of HF (56%), septic shock (15%) and stroke (12%). There was need
for urgent referral to surgery in 38% of P. The in-hospital mortality was
higher than other P with IE (21% vs 13%). 
Conclusion The PVE is associated with a poor prognosis at short term. Its
adverse developments should lead to the early identification of riskier P and
timely consideration of the possible benefit of surgery.
The author hereby declares no conflict of interest
0506
The impact of age on the characteristics of the mitral stenosis:
a retrospective study
Sanae Benhaourech, Kaoutar Kharbouche*, Wafae Bahtouri, Rachida Habbal 
CHU Ibn Rochd, Casablanca, Maroc
*Corresponding author: alkaoutar11@hotmail.com (Kaoutar Kharbouche)
Introduction The main etiology of mitral stenosis is rheumatic fever. There
remains a significant problem in developing countries and persists also in
developed countries despite a marked decline in prevalence in recent decades.
It mainly affects young adults, however it changes clinical presentation in
older patients with more altered valvular anatomy. The objective of this work
is to analyze the particularity of the mitral stenosis in the Moroccan elderly
over 50 years.
Materials and methods This is a descriptive and analytical retrospective
study, conducted in Ibn Rochd Center of Cardiology from January to June
2014, which included 45 patients with a sever mitral stenosis, devided into
2 groups: Group I: 24 patients <50 years group II: 21 patients ≥50ans. 
Statistical analysis was performed on IBM SPSS Statistics 20.
Results In our series there was a female predominance in the 2 groups (79%
vs 62%, group I, group II). In patients over 50 years, the atrial fibrillation was
more common (50% vs 70%) (p: 0.005), left atrium was more dilated (p 0.05 for
the diameter of the OG, and p: 0.046 to the surface of the OG), average gradient
was higher (p 0.044), the valves were more calcified (p:0.02), the history percuta-
neous mitral dilation was more frequent in group II (p: 0.009).
Conclusion The mitral stenosis of elderly has more impact on the cardiac
arrhythmia, the size of the OG, the severity of the gradient, and on valvular
anatomy that is more calcified.
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Objectives Valvular heart disease still common despite improved health
conditions that have reduced the incidence of rheumatic fever. Surgical and
interventional indications have expanded and today we operate at early stages,
sometimes even an asymptomatic stage. Valvular reoperation is required in
about 15% of cases during the evolution of an operated valve disease. We
report in this study the results of surgical valvular reoperations to identify the
indications for these reoperations.
Methods This is a retrospective study of 45 patients aged between 18 and 70
years, admitted to the cardiology department from January 2011 to July 2013,
and having a valve disease already operated and requiring reoperation.
Results Our series consisted of 45 patients; the average age is 41 years.
73% of patients are women and 27% of men (sex ratio of 3). The mitral valve
reoperations are motivated in most cases by a restenosis after a surgical com-
missurotomy (84%) and in 7% of cases by a prosthetic dysfunction, while
aortic valve reoperations are represented primarily by the dysfunction of pros-
thesis (44%) and aortic regurgitation neglected (56%). Finally, the reoperation
on the tricuspid valve is dominated essentially by regurgitation neglected
during the first intervention (62%). The average time between the two inter-
ventions, any kind confused, is 21 years, but this “timing” is variable if we
take into consideration the repair technique.
Conclusion Cardiac reoperations may occur during the evolution of a
valvulopathy. The patient should be warned of this and the possibility of
reoperation should be considered at the first cardiac surgery. Good initial car-
diac evaluation is needed to overcome the risk of reoperation for valve disease
neglected. 
Keywords reoperation, prosthesis dysfunction, degeneration, bioprostheses,
valvuloplasty, commissurotomy. 
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